Publication: Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors
Loading...
Program
relationships.isAuthorOf
Author
Deniz, Semanur
SANCAR, MESUT
OKUYAN, BETÜL
ATA, PINAR
Ozakpinar, Ozlem Bingol
TALAS, Anil
GUNES, Tufan
CALISKAN, Mecit
Izzettin, Fikret Vehbi
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: The aim of this study is to determine relationship of cytochrome P-450 2C19 (CYP2C19) enzymes polymorphism, side effects, and medication adherence in patients who have been diagnosed with major depression and have utilized selective serotonin reuptake inhibitors.
Description
Source
Keywords
Keywords
Citation
Deniz S., SANCAR M., OKUYAN B., ATA P., Ozakpinar O. B. , TALAS A., GUNES T., CALISKAN M., Izzettin F. V. , -Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors-, KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, ss.152-160, 2016